Boston Scientific Stock News

An analysis of data from 6K patients with non-valvular atrial fibrillation found that Boston Scientific (BSX) WATCHMAN FLX implant led to very low rates of adverse events.

This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management.

Endoscopy Equipment Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow. Northbrook, IL -- ( SBWIRE ) -- 02/24/2022 -- This report aims to provide detailed insights into the global endoscopy equipment market . It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market. Expected Revenue Growth: The global endoscopy equipment market is projected to reach USD 39.3 billion by 2026 from USD 27.3 billion in 2021, at a CAGR of 7.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=689 Key Factors Driving Market Growth: The key factors driving the growth of endoscopy equipment market include favorable government initiatives, rising number of hospitals and growing hospital investments in endoscopy facilities, technological advancements, and rising prevalence of diseases that require endoscopy.

A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance.

New York, USA, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Peripheral Vascular Devices Market is Estimated to Surpass USD 13 Billion by 2026 As per DelveInsight analysis, the demand for Peripheral Vascular Devices is increasing due to the rapid rise in cardiovascular and peripheral vascular diseases prevalence, as well as the approval of new and improved products by market players along with the rising frequency of lifestyle disorders such as diabetes and hypertension. DelveInsight''s Peripheral Vascular Devices Market Insights report provides the current and forecast Peripheral Vascular Devices market, upcoming device innovation, individual market shares, challenges, drivers, barriers, and market trends and key Peripheral Vascular Device companies in the market. Key Takeaways from the Peripheral Vascular Devices Market report According to DelveInsight analysis, North America is expected to dominate the Peripheral Vascular Devices market during the forecast period. Key Peripheral Vascular Device companies working in the global market are Medtronic, Boston Scientific Corporation, B.

Viking Global leader Andreas Halvorsen (Trades, Portfolio) disclosed his portfolio for the final quarter of 2021 last week.

The decline from September 2021 in Medical Device stocks was healthy. Similar price structures provide confidence in coming upside.

This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management.

(Reuters) – The U.S. Federal Trade Commission said it has approved certain modifications to medical device company Boston Scientific Corp’s divestiture agreements.

The U.S. Federal Trade Commission said it has approved certain modifications to medical device company Boston Scientific Corp’s divestiture agreements.

FTC approves modifications to Boston Scientific divestiture agreement

The U.S. Federal Trade Commission said it has approved certain modifications to medical device company Boston Scientific Corp's divestiture agreements.

We believe that Boston Scientific stock is a good buying opportunity at the current levels. Earlier this month the company released its Q4 earnings, which were better than our estimates.

We believe that Boston Scientific stock is a good buying opportunity at the current levels. Earlier this month the company released its Q4 earnings, which were better than our estimates.

The medical device maker has invested $1 billion in startups over the past decade